Skip to content

The Effect of Infusion Pressure on the Outcomes of Phacoemulsification Surgery; the ENHANSE Study

The Enhanse Study The Effect of Infusion Pressure on the Outcomes of Phacoemulsification Surgery

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04637685
Acronym
ENHANSE
Enrollment
70
Registered
2020-11-20
Start date
2021-03-01
Completion date
2023-09-01
Last updated
2020-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Brief summary

The effect of infusion pressure on the outcomes of phacoemulsification surgery.

Detailed description

The Centurion phacoemulsification system with active sentry allows efficient cataract surgery with safe use of high vacuums, whilst allowing low and physiological infusion pressures, significantly lower than other surgical systems. There are reasons to expect that this will lead to patient benefit but it is uncertain if low infusion pressure during phacoemulsification will lead to improved outcomes. This is of particular interest in patients with vascular retinopathies such as diabetic retinopathy where the retinal vasculature is compromised, as well as glaucoma and other optic neuropathies where there is established nerve fibre layer loss. The investigator will carry out a feasibility study with a two surgeon RCT of 70 patients with diabetic retinopathy and/or glaucoma undergoing phacoemulsification with randomisation of two different infusion pressures (low (30mmHg) versus the higher pressure (\ 70mmHg) as currently used) using the active sentry system with assessment of a range of exploratory endpoints.

Interventions

DEVICECenturion Phacoemulsification System

Infusion Pressure

Sponsors

South Tyneside and Sunderland NHS Foundation Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

All outcome assessors will be masked to treatment group allocation. The surgeon will not be masked.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patients with cataract undergoing routine phacoemulsification with either diabetic retinopathy or glaucoma of any degree

Exclusion criteria

* Dense cataract precluding adequate retinal imaging * posterior polar cataract * subluxated cataract, * other vision affecting pathology, * severe glaucoma

Design outcomes

Primary

MeasureTime frameDescription
Recruitment rateFrom the start to the end of the 10 month planned recruitment periodThe study has been designed as a feasibility study to assess recruitment rate. We will measure rate of recruitment to study (persons per month)

Secondary

MeasureTime frameDescription
Retinal thickness on SD OCTBetween baseline and day 40The above will be measured preoperatively and compared with day 40
Foveal avascular zone size on optical coherence tomography angiography between baseline and day 40Between baseline and day 40The above will be measured preoperatively and compared with day 40

Contacts

Primary ContactSteve Dodds
steven.dodds@chsft.nhs.uk+441915699039
Backup ContactDavid Steel
david.steel@chsft.nhs.uk+441915656256

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026